Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells
Article in Journal of Drug Targeting (February 2024)
The most recent citing publications are shown below. View all 116 publications that cite this research output on Dimensions.
Prodigiosin/celecoxib-loaded into zein/sodium caseinate nanoparticles as a potential therapy for triple negative breast cancer
Article in Scientific Reports (January 2024)
Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells
Article in Medical Oncology (August 2023)